Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

42.16
BATS BZX Real-Time Price
As of 2:50pm ET
 +0.58 / +1.39%
Today’s Change
31.38
Today|||52-Week Range
109.10
-55.22%
Year-to-Date

Today’s Trading

Previous close41.58
Today’s open41.33
Day’s range40.76 - 42.76
Volume57,544
Average volume (3 months)1,297,760
Market cap$3.6B
Dividend yield--
Data as of 2:50pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+28.87%
Earnings growth (this year)-39.99%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-18.72%
P/E ratioNM
Price/Sales192.40
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-0.44-0.06%
ENDPEndo International P...+0.02+0.09%
PTHNPatheon NV+0.03+0.12%
ACADACADIA Pharmaceutica...+0.98+3.70%
Data as of 2:51pm ET, 12/02/2016

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)-$1.32
Annual revenue (last year)$41.1M
Annual profit (last year)-$290.1M
Net profit margin-705.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs